XPER compared with AMRX: revenue, margins and what each company keeps, and the suppliers and customers both name

XPERXperi Inc.

Mkt capRevenueRevenue

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

XPERXperi Inc.

AMRXAmneal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only XPER 1

PNCPNC Bank, National Associationsupplier

Shared 0

No shared counterparties.

Only AMRX 14

—Customer Aunlistedcustomer

—Kashiv Biosciencesunlistedsupplier

—ApiJect Systemsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

BIAL-Portela & Ca

unlistedsupplier

10 more · AMRX chain ›

XPERXperi Inc.

5.43· pre 5.34· delayed

Mkt cap$262.4MRevenue$114MQ2 FY26Revenue$448MFY25

AMRXAmneal Pharmaceuticals, Inc.

20.44· pre 20.44· delayed

Pre-marketNov 2 '26delayed

Mkt cap$6.9BRevenue$796MQ2 FY26Revenue$3.0BFY25

Compare

Pre-marketNov 2 '26delayed

XPERXperi Inc.

AMRXAmneal Pharmaceuticals, Inc.

5.43pre 5.34delayed

Price

20.44pre 20.44delayed

$262.4M

Mkt cap

$6.9B

Q2 FY26$114M

Revenue

$796MQ2 FY26

FY25$448M

Revenue

$3.0BFY25

XPER5.43vsAMRX20.44Pre-marketNov 2 '26delayed